Bukwang Pharm to Host Investor Call on Q3 Results and R&D Progress

Bukwang Pharm will host an investor relations call via Zoom on Oct. 23, 2026, at 10:30 a.m. The call will cover third-quarter 2026 financial results and R&D updates. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bukwang Pharm. Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015800450), on October 15, 2026, and is solely responsible for the information contained therein. (C)